(Q38014500)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Anurag Agrawal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Lesley A Houghton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Gastroenterology & Hepatology

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

383-398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

Functional bowel disorders

2 February 2020

cites work

1 reference

Symptom differences in moderate to severe IBS patients based on predominant bowel habit

21 January 2018

1 reference

Bloating in constipation: relevance of intraluminal gas handling

21 January 2018

1 reference

Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review

21 January 2018

1 reference

Genetics of irritable bowel syndrome

21 January 2018

1 reference

Postinfectious irritable bowel syndrome

21 January 2018

1 reference

Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre.

21 January 2018

1 reference

Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome

21 January 2018

1 reference

Phenotypic variation of colonic motor functions in chronic constipation

21 January 2018

1 reference

Guidelines on the irritable bowel syndrome: mechanisms and practical management.

21 January 2018

1 reference

Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea

21 January 2018

1 reference

Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception

21 January 2018

1 reference

Functional GI disorders: from animal models to drug development

21 January 2018

1 reference

Bloating and distention in irritable bowel syndrome: the role of visceral sensation

21 January 2018

1 reference

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

21 January 2018

1 reference

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

21 January 2018

1 reference

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

21 January 2018

1 reference

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments

21 January 2018

1 reference

Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome.

21 January 2018

1 reference

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome

21 January 2018

1 reference

Differential expression of toll-like receptors in patients with irritable bowel syndrome.

21 January 2018

1 reference

Prokaryotes: the unseen majority

21 January 2018

1 reference

The human gut microbiome: ecology and recent evolutionary changes

21 January 2018

1 reference

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

Human milk glycobiome and its impact on the infant gastrointestinal microbiota

21 January 2018

1 reference

Gut flora in health and disease

21 January 2018

1 reference

Development of the human gastrointestinal microbiota and insights from high-throughput sequencing

21 January 2018

1 reference

The putative role of the intestinal microbiota in the irritable bowel syndrome

21 January 2018

1 reference

Interdigestive myoelectric complex in germ-free rats.

21 January 2018

1 reference

Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo.

21 January 2018

1 reference

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

21 January 2018

1 reference

Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening

21 January 2018

1 reference

Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice

21 January 2018

1 reference

The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease

21 January 2018

1 reference

Principles and clinical implications of the brain-gut-enteric microbiota axis

21 January 2018

1 reference

An in vitro assessment of the effects of broad-spectrum antibiotics on the human gut microflora and concomitant isolation of a Lactobacillus plantarum with anti-Candida activities

21 January 2018

1 reference

Rifaximin therapy for patients with irritable bowel syndrome without constipation

21 January 2018

1 reference

Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls

21 January 2018

1 reference

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

21 January 2018

1 reference

Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

The degree of breath methane production in IBS correlates with the severity of constipation

21 January 2018

1 reference

Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress

21 January 2018

1 reference

Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity

21 January 2018

1 reference

The role of intestinal gas in functional abdominal pain

21 January 2018

1 reference

Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome

21 January 2018

1 reference

Abdominal distension in female patients with irritable bowel syndrome: exploration of possible mechanisms.

21 January 2018

1 reference

Abnormal colonic fermentation in irritable bowel syndrome

21 January 2018

1 reference

Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives

21 January 2018

1 reference

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

21 January 2018

1 reference

A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

21 January 2018

1 reference

Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

21 January 2018

1 reference

Intestinal microecology and quality of life in irritable bowel syndrome patients

21 January 2018

1 reference

Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies

21 January 2018

1 reference

Irritable bowel syndrome--post salmonella infection.

21 January 2018

1 reference

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

21 January 2018

1 reference

The role of psychological and biological factors in postinfective gut dysfunction

21 January 2018

1 reference

Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role?

21 January 2018

1 reference

Sigmoid-colonic motility in health and irritable bowel syndrome: a role for 5-hydroxytryptamine.

21 January 2018

1 reference

Role of serotonin in the pathophysiology of the irritable bowel syndrome

21 January 2018

1 reference

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

21 January 2018

1 reference

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

21 January 2018

1 reference

The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors

21 January 2018

1 reference

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine

21 January 2018

1 reference

Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome

21 January 2018

1 reference

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

21 January 2018

1 reference

Some insights into the derivation and early uses of the word 'probiotic'.

21 January 2018

1 reference

Studies on the Transformation of the Intestinal Flora, with Special Reference to the Implantation of Bacillus Acidophilus: I. Feeding Experiments with Albino Rats

21 January 2018

1 reference

Studies on the Transformation of the Intestinal Flora, with Special Reference to the Implantation of Bacillus Acidophilus: II. Feeding Experiments on Man

21 January 2018

1 reference

Probiotics in man and animals

21 January 2018

1 reference

Probiotics in perspective.

21 January 2018

1 reference

Guidance for substantiating the evidence for beneficial effects of probiotics: impact of probiotics on digestive system metabolism

21 January 2018

1 reference

Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy

21 January 2018

1 reference

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial

21 January 2018

1 reference

Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity

21 January 2018

1 reference

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.

21 January 2018

1 reference

Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation.

21 January 2018

1 reference

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study

21 January 2018

1 reference

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 January 2018

1 reference

VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study

21 January 2018

1 reference

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

21 January 2018

1 reference

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

21 January 2018

1 reference

Placebo effect in patients with irritable bowel syndrome.

21 January 2018

1 reference

Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study

21 January 2018

1 reference

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Prebiotic effects: metabolic and health benefits

21 January 2018

1 reference

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

21 January 2018

1 reference

The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders.

21 January 2018

1 reference

Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study

21 January 2018

1 reference

Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study

21 January 2018

1 reference

Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: an open-label, partially controlled, 1-year extension of a previously published controlled clinical trial

21 January 2018

1 reference

Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome

21 January 2018

1 reference

Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction

21 January 2018

1 reference

Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats

21 January 2018

1 reference

The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.

21 January 2018

1 reference

Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction

21 January 2018

1 reference

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

21 January 2018

1 reference

Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages.

21 January 2018

1 reference

Modulation of human dendritic cell phenotype and function by probiotic bacteria

21 January 2018

1 reference

Functional modulation of enterocytes by gram-positive and gram-negative microorganisms

21 January 2018

1 reference

Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures

21 January 2018

1 reference

Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants.

21 January 2018

1 reference

Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling

21 January 2018

1 reference

Probiotics regulate the expression of COX-2 in intestinal epithelial cells

21 January 2018

1 reference

Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism

21 January 2018

1 reference

Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function

21 January 2018

1 reference

The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study

21 January 2018

1 reference

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life

21 January 2018

1 reference

Treatment of irritable bowel syndrome with Saccharomyces boulardii.

21 January 2018

1 reference

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.12.9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22646259%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference